Statin use and risk of cutaneous melanoma: a nationwide nested case-control study

Reza Ghiasvand^{1

2

3}, Leon A M Berge^{1

3

4}, Bettina K Andreassen¹, Adele C Green^{5

6}, Marie Al Rahmoun⁷, Agnès Fournier⁷, Marina Kvaskoff⁷, Marit B Veierød⁴, Trude E Robsahm^{1

3}

Affiliations

¹ Department of Research, Cancer Registry of Norway, Oslo, Norway.
² Oslo Centre for Biostatistics and Epidemiology.
³ Institute for Cancer Research.
⁴ Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences; University of Oslo, Norway.
⁵ QIMR Berghofer Medical Research Institute, Brisbane, Australia.
⁶ CRUK Manchester Institute, University of Manchester, Manchester, UK.
⁷ Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, 'Exposome and Heredity' team, CESP, F-94805, Villejuif, France.

Reza Ghiasvand et al. Br J Dermatol. 2023.

. 2023 May 24;188(6):805-807.

doi: 10.1093/bjd/ljad057.

¹ Department of Research, Cancer Registry of Norway, Oslo, Norway.
² Oslo Centre for Biostatistics and Epidemiology.
³ Institute for Cancer Research.
⁴ Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences; University of Oslo, Norway.
⁵ QIMR Berghofer Medical Research Institute, Brisbane, Australia.
⁶ CRUK Manchester Institute, University of Manchester, Manchester, UK.
⁷ Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, 'Exposome and Heredity' team, CESP, F-94805, Villejuif, France.

No abstract available

Conflict of interest statement

Conflicts of interest The authors declare they have no conflicts of interest.